Company / Gross Margin
Amgen Gross Margin History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
18.1%
FY2019
5-year range
-
FY2016-FY2019
Trend
-2.2%
vs FY2018
Sector context
#27 of 26
Health Care
What the data says
Among 26 Health Care companies, Amgen is in the bottom 1% for gross margin. Gross Margin remained relatively stable over the past 4 years, with values between 18.1% and 18.5%.
Based on SEC 10-K filings.
18.1% in FY2019 with a 3-year CAGR of -0.3%.
Remained stable around 18.1% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -0.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom -4% in Health CareTop 104% of 26This company 18.1% Sector average 61.9%
▼
-70.7% below sector average
Key checks
Key Insights
- In FY2019, gross margin decreased 2.2% year-over-year.
- Currently 43.8pp below the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | 18.1% | -2.2% |
| FY2018 | 18.5% | +0.7% |
| FY2017 | 18.4% | +0.2% |
| FY2016 | 18.4% | +3.6% |
As of FY2019 · SEC Form 10-K · Last checked Jun 21, 2026